These 96-well plates are pre-configured with the most appropriate TaqMan® Gene Expression Assays for a specific biological process, pathway, or disease state. Each plate contains predefined assays and endogenous controls dried-down in the wells, ready for accurate assessment of an entire gene signature in one simple experiment. The panel of assays in the TaqMan® Array 96-well Human Angiogenesis Plate targets known angiogenesis growth factors like VEGF as well as matrix derived inhibitors such as endostatin. Additionally, the panel contains markers and targets for angiogenesis and lymphangiogenesis.